Principal Research Scientist
AbbVie
South San Francisco, California
Dr. Michelle Graham is a Principal Research Scientist at AbbVie in the Quantitative, Translational and ADME Sciences (QTAS) group and uses her diverse biomedical background to translate meaningful pharmacodynamic (PD) biomarkers into clinical trials. Dr. Graham leads a variety of efforts to identify FACS-based PD biomarkers in the preclinical and clinical setting in support of first-in-human (FIH) dosing decisions and biomarker strategies that span immunologically relevant therapeutic areas. Michelle has a strong background in immunology with over 15 years of flow cytometry experience. Prior to AbbVie, Michelle received her PhD in biomedical sciences from UCSF, followed by postdoctoral work at Stanford University in food allergy. Scientific accomplishments include publications ranging from neuroimmunology to hematological malignancies.
Tuesday, October 24, 2023
10:00 AM – 10:30 AM ET
Hot Topic: Understanding Data Needs for AI/ML Approaches During Preclinical Development
Wednesday, October 25, 2023
3:00 PM – 4:00 PM ET